Inhibikase Therapeutics, Inc. (IKT): SCHEDULE 13G/A filed Aug 13, 2026

Form type

SCHEDULE 13G/A

Filing date

Aug 13, 2026

Accession number

0001875620-26-000017

Filer

Inhibikase Therapeutics, Inc. (CIK 1750149)